These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21495027)

  • 1. Reirradiation for recurrent medulloblastoma.
    Bakst RL; Dunkel IJ; Gilheeney S; Khakoo Y; Becher O; Souweidane MM; Wolden SL
    Cancer; 2011 Nov; 117(21):4977-82. PubMed ID: 21495027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
    Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
    Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
    Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial brachytherapy using stereotactic implanted (125)iodine seeds for recurrent medulloblastoma.
    El Majdoub F; Simon T; Hoevels M; Berthold F; Sturm V; Maarouf M
    Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):532-7. PubMed ID: 21440428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation.
    Bouffet E; Hawkins CE; Ballourah W; Taylor MD; Bartels UK; Schoenhoff N; Tsangaris E; Huang A; Kulkarni A; Mabbot DJ; Laperriere N; Tabori U
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1541-8. PubMed ID: 22245198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome and prognostic factors of radiation therapy for medulloblastoma.
    Rieken S; Mohr A; Habermehl D; Welzel T; Lindel K; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e7-e13. PubMed ID: 21345611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
    Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton therapy for reirradiation of progressive or recurrent chordoma.
    McDonald MW; Linton OR; Shah MV
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1107-14. PubMed ID: 24267972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of surgery and reirradiation for recurrent ependymoma.
    Merchant TE; Boop FA; Kun LE; Sanford RA
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):87-97. PubMed ID: 18406885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reirradiation after salvage surgery and microvascular free flap reconstruction for recurrent head and neck carcinoma.
    Suh JD; Kim BP; Abemayor E; Sercarz JA; Nabili V; Liu JH; Juillard GJ; Blackwell KE
    Otolaryngol Head Neck Surg; 2008 Dec; 139(6):781-6. PubMed ID: 19041503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
    Watkins JM; Shirai KS; Wahlquist AE; Stuart RK; Chaudhary UB; Garrett-Mayer E; Day TA; Gillespie MB; Sharma AK
    Head Neck; 2009 Apr; 31(4):493-502. PubMed ID: 19156831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
    Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
    J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
    Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S
    Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.
    Kramer NM; Horwitz EM; Cheng J; Ridge JA; Feigenberg SJ; Cohen RB; Nicolaou N; Sherman EJ; Babb JS; Damsker JA; Langer CJ
    Head Neck; 2005 May; 27(5):406-14. PubMed ID: 15719391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.
    Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure.
    Douglas JG; Barker JL; Ellenbogen RG; Geyer JR
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1161-4. PubMed ID: 15001259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Well differentiated astrocytoma occurring nine years after radiation therapy for medulloblastoma.
    Osumi AK; Mclendon RE; Tien RD; Friedman HS; Graham M; Hockenberger B; Halperin EC; Oakes WJ
    Clin Neuropathol; 1994; 13(5):281-5. PubMed ID: 7805312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses.
    Sethi RV; Giantsoudi D; Raiford M; Malhi I; Niemierko A; Rapalino O; Caruso P; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):655-63. PubMed ID: 24521681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.